Literature DB >> 10999439

Effects of red ginseng upon vascular endothelial function in patients with essential hypertension.

J Sung1, K H Han, J H Zo, H J Park, C H Kim, B H Oh.   

Abstract

This study is to estimate the effect of Korean red ginseng on vascular endothelial cell dysfunction in patients with hypertension. Seventeen patients with hypertension who were divided into ginseng-treated (7) and non-treated (10) groups and 10 normotensive subjects were included. To assess the function of the vascular endothelial cell, changes of forearm blood flow to infusion of acetylcholine, sodium nitroprusside and bradykinin in incremental doses were measured by venous occlusion plethysmography. In the ginseng-treated hypertensive group, forearm blood flows at the highest dose of acetylcholine and bradykinin were significantly higher than those of the non-treated hypertensive group and were not different from those of the control group. In the case of sodium nitroprusside infusion, no significant differences were observed between the control, non-treated and treated groups. In conclusion, Korean red ginseng can improve the vascular endothelial dysfunction in patients with hypertension possibly through increasing synthesis of nitric oxide.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10999439     DOI: 10.1142/S0192415X00000258

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  26 in total

1.  Blood pressure-lowering effect of Korean red ginseng associated with decreased circulating Lp-PLA2 activity and lysophosphatidylcholines and increased dihydrobiopterin level in prehypertensive subjects.

Authors:  Tae Woong Cha; Minjoo Kim; Minkyung Kim; Jey Sook Chae; Jong Ho Lee
Journal:  Hypertens Res       Date:  2016-02-04       Impact factor: 3.872

2.  Notoginsenoside R1 reduces blood pressure in spontaneously hypertensive rats through a long non-coding RNA AK094457.

Authors:  Ying Yang; Peng Xi; Yuan Xie; Cuimei Zhao; Jiahong Xu; Jinfa Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 3.  Therapeutic potential of ginseng in the management of cardiovascular disorders.

Authors:  Morris Karmazyn; Melissa Moey; Xiaohong Tracey Gan
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

Review 4.  Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension.

Authors:  Morris Karmazyn; Xiaohong Tracey Gan
Journal:  Mol Cell Biochem       Date:  2020-09-17       Impact factor: 3.396

Review 5.  Use of herbal products and potential interactions in patients with cardiovascular diseases.

Authors:  Ara Tachjian; Viqar Maria; Arshad Jahangir
Journal:  J Am Coll Cardiol       Date:  2010-02-09       Impact factor: 24.094

Review 6.  Panax ginseng: a systematic review of adverse effects and drug interactions.

Authors:  Joanna Thompson Coon; Edzard Ernst
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

7.  Ginsenoside Rb1 Enhances Keratinocyte Migration by a Sphingosine-1-Phosphate-Dependent Mechanism.

Authors:  Kyong-Oh Shin; Sung Jay Choe; Yoshikazu Uchida; Inyong Kim; Yoonhwa Jeong; Kyungho Park
Journal:  J Med Food       Date:  2018-08-27       Impact factor: 2.786

Review 8.  Ginseng compounds: an update on their molecular mechanisms and medical applications.

Authors:  Jian-Ming Lü; Qizhi Yao; Changyi Chen
Journal:  Curr Vasc Pharmacol       Date:  2009-07       Impact factor: 2.719

Review 9.  Current evaluation of the millennium phytomedicine- ginseng (II): Collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine.

Authors:  Lee Jia; Yuqing Zhao; Xing-Jie Liang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

10.  Ginsenoside Rg3 inhibits phenylephrine-induced vascular contraction through induction of nitric oxide synthase.

Authors:  Nak Doo Kim; Eun Mi Kim; Keon Wook Kang; Min Kyung Cho; So Yeon Choi; Sang Geon Kim
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.